Sacher M, Kobsa A, Shmerling D H
Arch Dis Child. 1978 Aug;53(8):639-41. doi: 10.1136/adc.53.8.639.
P-Amino-benzoic acid (PABA) is split specifically by pancreatic chymotrypsin from the synthetic tripeptide N-benzoyl-L-tyrosyl-PABA. The urinary excretion of absorbed PABA serves as an index for exocrine pancreatic function. The peptide (0.015 g/kg) was administered orally to 20 controls (aged between 5 months and 16 years), 6 patients with exocrine pancreatic insufficiency caused by cystic fibrosis (CF), and 9 newborn infants. In the controls the mean 6-hour PABA recovery was 58.5% (+/- 11.2 SD). Recovery in patients with CF was lower (P less than 0.001) with no overlap. In newborn infants the mean 6-hour PABA recovery was 23.4 (+/- 17.7 SD); overlapping in 3 instances with the results in CF patients. This simple, noninvasive test thus appears promising and merits further investigation in younger infants, especially newborns.
对氨基苯甲酸(PABA)可被胰凝乳蛋白酶从合成三肽N-苯甲酰-L-酪氨酰-PABA中特异性裂解。吸收后的PABA经尿液排泄可作为胰腺外分泌功能的一项指标。将该肽(0.015 g/kg)口服给予20名对照者(年龄在5个月至16岁之间)、6名由囊性纤维化(CF)导致胰腺外分泌功能不全的患者以及9名新生儿。在对照者中,6小时PABA的平均回收率为58.5%(±11.2标准差)。CF患者的回收率较低(P<0.001),且无重叠。新生儿6小时PABA的平均回收率为23.4(±17.7标准差);有3例结果与CF患者的结果重叠。因此,这项简单的非侵入性检测似乎很有前景,值得在更小的婴儿尤其是新生儿中进一步研究。